San Diego Union-Tribune - CAMBRIDGE, Mass. – Genzyme Corp. on Monday won backing from Bioenvision Inc. shareholders to acquire the biotechnology company for $345 million, closing a contentious process in which the shareholder vote was reopened to secure majority support ...
